Business Context and Reporting Period
This Form 6-K filing by GSK plc (the "Company") reports a transaction in its own shares for the month of October 2025. The filing details a share repurchase executed on October 13, 2025, pursuant to a non-discretionary agreement with BNP Paribas SA, announced on September 30, 2025.
Key Financial Metrics
The filing focuses exclusively on capital allocation activities regarding share buybacks. It does not contain operational financial metrics such as revenue, profit, cash flow, margins, or debt levels.
- Shares Purchased (Oct 13, 2025): 340,000 ordinary shares
- Volume-Weighted Average Price (VWAP): 1,623.26 GBp
- Price Range: 1,614.50 GBp (Low) to 1,633.00 GBp (High)
- Cumulative Buyback (since Sept 30, 2025): 3,244,000 ordinary shares
- Total Treasury Shares Held: 250,708,844
- Ordinary Shares in Issue (excluding Treasury): 4,064,704,985
- Treasury Voting Rights Percentage: 6.17%
Material Changes
Following the purchase on October 13, 2025, the Company's total holding of treasury shares increased to 250,708,844. The number of ordinary shares in issue remains 4,064,704,985. The percentage of voting rights attributable to treasury shares is confirmed at 6.17% in accordance with DTR 5.5.1R.
Guidance, Outlook, and Risks
The filing contains no new financial guidance, outlook, or management commentary regarding operational performance. It includes a standard cautionary statement regarding forward-looking statements, noting that actual results may differ materially due to risks described in the Company's 2024 Annual Report on Form 20-F and Q2 2025 Results.
Investor Verification Checklist
- Verify the total number of treasury shares held (250,708,844) against the latest Form 20-F or quarterly reports.
- Confirm the remaining capacity under the existing buyback programme announced on September 30, 2025.
- Review the "Risk Factors" section of the 2024 Form 20-F for context on the forward-looking statement disclaimer.
- Check the denominator for voting rights calculations (4,064,704,985) for compliance with FCA Disclosure Guidance and Transparency Rules.